Dawn Barry will be responsible for leading operations, communicating and implementing company mission, and guiding overall strategy, direction, and growth.
Thermo Fisher Scientific and Illumina have announced a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers who conduct scientific studies on Illumina’s next-generation sequencing platforms.
Several individual investors from Illumina have invested in an open-source genomics database that uses the same technology employed by Bitcoin.
NanoCellect Biomedical today announced the completion of a $10 million Series B financing round, including convertible notes.
Illumina is opening its first Customer Solutions Center in France, where it will train up to 1,000 scientists a year in latest genomics technologies.
Scientists in Scotland have gained access to the most up-to-date gene sequencing technology, aiding research to better understand human and animal diseases.
ASHG: This year’s Presidential Symposium will feature a discussion of global health and genomics between two absolute legends in health & science.
Direct Genomics has proved how its single-molecule sequencing platform, GenoCare can successfully sequence Escherichia coli.